Neurorehabilitation and Spinal Unit, Institute of Pavia, Istituti Clinici Scientifici Maugeri IRCCS, Via Maugeri 4, 27100, Pavia, Italy.
Department of Clinical-Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy.
Sci Rep. 2021 Feb 25;11(1):4708. doi: 10.1038/s41598-021-84203-y.
Post-traumatic seizures (PTS) are a common and debilitating complication of traumatic brain injury (TBI) and could have a harmful impact on the progress of patient rehabilitation. To assess the effect of PTS and relative therapy on outcome in the initial phase after TBI, during the rehabilitation process when neuroplasticity is at its highest, we retrospectively examined the clinical data of 341 adult patients undergoing rehabilitation for at least 6 months post-TBI in our neurorehabilitation unit between 2008 and 2019. We correlated through logistic regression the occurrence of seizures and use of anti-seizure medication (ASM) with neurological and functional outcomes, respectively assessed with the Glasgow Coma Scale (GCS) and the Functional Independence Measure (FIM). PTS were documented in 19.4% of patients: early PTS (EPTS) in 7.0%; late PTS (LPTS) in 9.4%; both types in 3.0%. Patients who developed EPTS had an increased risk of developing LPTS (OR = 3.90, CI 95% 1.58-9.63, p = 0.003). Patients with LPTS had a significantly higher risk of worse neurological (p < 0.0001) and rehabilitation (p < 0.05) outcome. Overall, 38.7% of patients underwent therapy with ASM; prophylactic therapy was prescribed in 24.0% of patients, of whom 14.6% subsequently developed seizures. Mortality was associated with a lower FIM and GCS score on admission but not significantly with PTS. The use of ASM was associated with a worse rehabilitation outcome, independently of the onset of epilepsy during treatment. LPTS appear to exert a negative impact on rehabilitation outcome and their occurrence is not reduced by prophylactic therapy, whereas EPTS do not influence outcome. Our findings caution against the generic use of prophylactic therapy to prevent post-traumatic epilepsy in patients with TBI.
创伤性脑损伤(TBI)后癫痫发作(PTS)是一种常见且使人虚弱的并发症,可能对患者康复进程产生有害影响。为了评估 PTS 及其相关治疗对 TBI 后初始康复阶段的影响,即神经可塑性最高的时期的康复结果,我们回顾性分析了 2008 年至 2019 年期间在我们神经康复科接受康复治疗至少 6 个月的 341 例成年 TBI 患者的临床数据。我们通过逻辑回归将癫痫发作的发生和抗癫痫药物(ASM)的使用与分别用格拉斯哥昏迷量表(GCS)和功能独立性测量(FIM)评估的神经和功能结果相关联。在 19.4%的患者中记录到 PTS:早期 PTS(EPTS)占 7.0%;晚期 PTS(LPTS)占 9.4%;两种类型均有的占 3.0%。发生 EPTS 的患者发生 LPTS 的风险增加(OR=3.90,95%CI 1.58-9.63,p=0.003)。发生 LPTS 的患者神经功能(p<0.0001)和康复结局(p<0.05)的恶化风险显著更高。总体而言,38.7%的患者接受了 ASM 治疗;预防性治疗在 24.0%的患者中开具,其中 14.6%的患者随后发生癫痫发作。死亡率与入院时较低的 FIM 和 GCS 评分相关,但与 PTS 无显著相关。ASM 的使用与康复结局较差相关,与癫痫发作的发生无关。LPTS 似乎对康复结局产生负面影响,且预防性治疗并不能降低其发生,而 EPTS 对结局没有影响。我们的研究结果提醒人们在 TBI 患者中预防性使用 ASM 以预防创伤后癫痫发作的方法具有普遍性。